GLP1

Business

U.S. dialysis volumes to rebound despite GLP-1 impact

Philiphotographer/iStock Unreleased via Getty Images Fresenius Medical Care (NYSE:FMS) expects U.S. dialysis volumes to bounce back this year after a…

Read More »
Business

Lilly could partner with Cipla to market GLP-1 drugs in India

JHVEPhoto Cipla, one of India’s largest pharmaceutical companies, is open to partnering with Eli Lilly (NYSE:LLY) to market Mounjaro and…

Read More »
Food & Drink

The Ozempic effect is real: Study zeroes in on GLP-1 users’ food needs

A recent study by food product innovation specialist Mattson finds that those taking anti-obesity medications such as Ozempic, Wegovy and…

Read More »
Business

FDA evaluating reports of GLP-1 drugs and negative side effects (NYSE:NVO)

Grandbrothers The FDA is evaluating reports that GLP-1 drugs such as Wegovy, Ozempic and Mounjaro may be associated with hair…

Read More »
Back to top button